- Home
- LEGH vs HUMA Comparison
LEGH vs HUMA Comparison
Compare LEGH & HUMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LEGH | HUMA |
|---|---|---|
| Founded | 2005 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Homebuilding | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 495.0M | 236.0M |
| IPO Year | 2018 | N/A |
Fundamental Metrics
Financial Performance| Metric | LEGH | HUMA |
|---|---|---|
| Price | $20.47 | $1.08 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 8 |
| Target Price | ★ $25.00 | $10.13 |
| AVG Volume (30 Days) | 126.6K | ★ 4.1M |
| Earning Date | 11-07-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.95 | N/A |
| Revenue | ★ $180,497,000.00 | $1,571,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $6.07 | $731.05 |
| P/E Ratio | $10.47 | ★ N/A |
| Revenue Growth | ★ 10.25 | N/A |
| 52 Week Low | $18.84 | $1.09 |
| 52 Week High | $29.45 | $6.77 |
Technical Indicators
Market Signals| Indicator | LEGH | HUMA |
|---|---|---|
| Relative Strength Index (RSI) | 48.95 | 34.01 |
| Support Level | $20.08 | $1.21 |
| Resistance Level | $20.87 | $1.32 |
| Average True Range (ATR) | 0.62 | 0.08 |
| MACD | 0.21 | -0.00 |
| Stochastic Oscillator | 73.33 | 7.78 |
Price Performance
Historical ComparisonAbout LEGH Legacy Housing Corporation (TX)
Legacy Housing Corp builds, sell, and finance manufactured homes and tiny houses that are distributed through a network of independent retailers and company-owned stores and also sold directly to manufactured home communities. The company also provides financing options to its customers to facilitate the sale of homes.
About HUMA Humacyte Inc.
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.